Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
ILCNavigating the Hep C Treatment and Cancer Risk MinefieldContradictory findings are driving disagreement over liver cancer risk after treatment with direct-acting antivirals for hepatitis C, and experts are shedding light on the way forward.
Nancy Reau, MD Rush University Medical Center, Chicago, Illinois Presentation: Magellan-2: Safety and efficacy of glecaprevir/pibrentasvir in liver or renal transplant adults with chronic hepatitis C genotype
1-6 infection Date: April 22, 2017